IDEX Corporation (IEX) Presents at Oppenheimer 21st Annual Industrial Growth Virtual Conference Transcript

NORTHBROOK, Ill.--(BUSINESS WIRE)-- #AdvancedManufacturing--IDEX Corp. (NYSE:IEX) announced a regular quarterly cash dividend of $0.73 per common share, its 126th consecutive regular quarterly payment.

IEX beats Q1 estimates and raises outlook as strong Health & Science Technologies demand and record orders signal momentum into 2026.

IDEX Corporation (IEX) Q1 2026 Earnings Call Transcript

Idex (IEX) came out with quarterly earnings of $2 per share, beating the Zacks Consensus Estimate of $1.78 per share. This compares to earnings of $1.75 per share a year ago.

Q1 2026 net sales were $886.9 million. The estimated revenue was $845.57 million.GAAP diluted EPS was $1.61. The estimated EPS was $1.41.Adjusted diluted EPS w

NORTHBROOK, Ill.--(BUSINESS WIRE)--IDEX Corporation (NYSE: IEX) today announced its financial results for the three-month period ended March 31, 2026. “We delivered a strong first quarter, with results ahead of our expectations led by continued momentum in our growth platforms within our Health & Science Technologies segment,” said Eric D. Ashleman, IDEX Corporation Chief Executive Officer and President. “Our first quarter results demonstrate that our strategy is working, with strong execut.

Cwm LLC raised its position in shares of IDEX Corporation (NYSE: IEX) by 144.8% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 14,431 shares of the industrial products company's stock after purchasing an additional 8,537 shares during the quarter. Cwm LLC's

IDEX Corporation has outperformed the S&P 500, with shares up 21.4% since November, driven by rising revenue, profits, and cash flow. IEX remains diversified across industries, with recent growth in Health & Science Technologies fueled by acquisitions and organic gains in semiconductors and aviation. Despite recent gains, IEX appears fairly valued on an absolute basis but trades at a discount relative to peers; a 'hold' rating is maintained.

Idex (IEX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.